PROCEPT INC
4, 1998-05-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: PERFORMANCE FUNDS TRUST, 40-17F2, 1998-05-11
Next: PROCEPT INC, 4, 1998-05-11




UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
The Aries Trust
c/o Paramount Capital Asset Management, Inc.
787 Seventh Avenue, 48th Floor
New York, New York 10019

2. Issuer Name and Ticker or Trading Symbol
   Procept, Inc. -- PRCTC

3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   04/98
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)

7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock, par value    |4/9/98| P  | |3,350,000         | A |  (1)      |17,682,761         |  D   |                           |
$.01 per share.            |      |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock, par value    |4/9/98|J(2)| |5,470,920         | A |  (2)      |17,682,761         |  D   |                           |
$.01 per share             |      |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|



<PAGE>

<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Class C Warrants to   |$0.50   |4/9/ | P  | |3,350,000  | A |4/9/ |4/9/ |Common Stock|3,350, |(1)    |8,820,920   | D |            |
purchase Common Stock |        |98   |    | |           |   |98   |03   |            |000    |       |            |   |            |
___________________________________________________________________________________________________________________________________|
Class C Warrants to   |$0.50   |4/9/ |J(2)| |5,470,920  | A |4/9/ |4/9/ |Common Stock|5,470, |(2)    |8,820,920   | D |            |
purchase Common Stock |        |98   |    | |           |   |98   |03   |            |920    |       |            |   |            |
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
Series A Preferred    |$1.09375|4/9/ |J(2)| |19,539     | D |6/30/|N/A  |Common Stock|1,786, |(2)    |0           | D |            |
Stock                 |        |98   |    | |           |   |97   |     |            |423    |       |            |   |            |
___________________________________________________________________________________________________________________________________|
New Warrants to       |$1.09375|4/9/ |J(2)| |2,134,036  | D |6/30/|6/30/|Common Stock|2,134, |(2)    |0           | D |            |
Purchase Common Stock |        |98   |    | |           |   |97   |02   |            |036    |       |            |   |            |
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
</TABLE>

Explanation of Responses:

(1)  The Common Stock and Class C Warrants  purchased on 4/9/98 were included in
     16.5 Units for which the Reporting Person paid a total of $1,457,250.
(2)  The  Common  Stock and Class C  Warrants  were  acquired  and the  Series A
     Preferred  Stock  and New  Warrants  were  disposed  of on April  9,  1998,
     pursuant to a Letter Agreement between the Issuer, the Reporting Person and
     the Aries Domestic Fund, L.P., dated January 13, 1998.

SIGNATURE OF REPORTING PERSON
/s/ Lindsay A. Rosenwald, M.D.
- -----------------------------
Name: Lindsay A. Rosenwald, M.D., President
Paramount Capital Asset Management, Inc., Investment Manager
The Aries Trust

DATE
05/8/98


<PAGE>

                                  Attachment A


        Reporting Person:           The Aries Trust
        Issuer:                     Procept Inc. (PRCTC)
        Statement For:              April/1998

         Paramount Capital Asset Management, Inc. ("Paramount"),  the Investment
Manager to The Aries Trust (the  "Trust"),  is also the  General  Partner of the
Aries Domestic Fund (the "Partnership"),  a Delaware limited partnership,  which
also owns  securities  of the Issuer.  Lindsay A.  Rosenwald,  M.D., is the sole
shareholder  of  Paramount.  Paramount  and Dr.  Rosenwald  disclaim  beneficial
ownership of the securities held by the Partnership and the Trust, except to the
extent of their pecuniary interest therein, if any.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission